Jinggong Liu

Dr. Jinggong Liu

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2021 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
SHShuai Huang
Shuai Huang
BCBihui Cao
Bihui Cao
JZJinling Zhang
Jinling Zhang
YFYunfei Feng
Yunfei Feng
LWLu Wang
Lu Wang
BLBaoxia Liang
Baoxia Liang
Cucurbitacin B (CuB) is a widely available triterpenoid molecule that exhibits various biological activities. Previous studies on the anti-tumour mechanism of CuB have mostly focused on cell apoptosis, and research on the ferroptosis-inducing effect has rarely been reported. Herein, we first discovered the excellent cytotoxicity of CuB towards human nasopharyngeal carcinoma cells and elucidated its potential ferroptosis-inducing mechanisms. Morphology alterations of mitochondrial ultrastructure, as observed via transmission electron microscopy, showed that CuB-treated cells undergo ferroptosis. CuB caused intracellular accumulation of iron ions and depletion of glutathione. Detailed molecular mechanism investigation confirmed that CuB both induced widespread lipid peroxidation and downregulated the expression of GPX4, ultimately initiating a multipronged mechanism of ferroptosis. Furthermore, CuB exhibited anti-tumour effects in vitro by inhibiting cellular microtubule polymerization, arresting cell cycle and suppressing migration and invasion. Finally, CuB significantly inhibited tumour progression without causing obvious side effects in vivo. Altogether, our study highlighted the therapeutic potential of CuB as a ferroptosis-inducing agent for nasopharyngeal cancer, and it provided valuable insights for developing effective anti-tumour agents with novel molecular mechanisms derived from natural products.

18 September 2020 in Frontiers in Chemistry
Verified
Journal Article
Open access
PDF file
JLJinggong Liu
Jinggong Liu
YLYongjin Li
Yongjin Li
SCSong Chen
Song Chen
YLYongpeng Lin
Yongpeng Lin
HLHaoqiang Lai
Haoqiang Lai
TCTianfeng Chen
Tianfeng Chen
Numerous pathological conditions, including cancer, inflammatory diseases, and neurodegenerative diseases, are accompanied by overproduction of reactive oxygen species (ROS). This makes ROS vital flagging molecules in disease pathology. ROS-responsive drug delivery platforms have been developed. Nanotechnology has been broadly applied in the field of biomedicine leading to the progress of ROS-responsive nanoparticles. In this review, we focused on the production and physiological/pathophysiological impact of ROS. Particular emphasis is put on the mechanisms and effects of abnormal ROS levels on oxidative stress diseases, including cancer, inflammatory disease, and neurodegenerative diseases. Finally, we summarized the potential biomedical applications of ROS-responsive nanocarriers in these oxidative stress diseases. We provide insights that will help in the designing of new ROS-responsive nanocarriers for various applications.

7 February 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SLShouang Lan
Shouang Lan
HHHuangjiang Huang
Huangjiang Huang
WLWenjun Liu
Wenjun Liu
CXChao Xu
Chao Xu
XLXiang Lei
Xiang Lei
XFXinqiang Fang
Xinqiang Fang

7 February 2024 in ACS Catalysis
Verified
Journal Article
Closed access
DLDefu Luo
Defu Luo
SNShengtong Niu
Shengtong Niu
FGFan Gong
Fan Gong
CXChao Xu
Chao Xu
SLShouang Lan
Shouang Lan
XFXinqiang Fang
Xinqiang Fang

26 December 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
SLShouang Lan
Shouang Lan
QCQinqin Cui
Qinqin Cui
DLDefu Luo
Defu Luo
SSSiyu Shi
Siyu Shi
CHChengyang He
Chengyang He
XFXinqiang Fang
Xinqiang Fang

15 July 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
WLWenjun Liu
Wenjun Liu
CRCaiyi Ren
Caiyi Ren
LZLiyuan Zhou
Liyuan Zhou
HLHaotian Luo
Haotian Luo
XMXiangjian Meng
Xiangjian Meng
XFXinqiang Fang
Xinqiang Fang